These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
299 related items for PubMed ID: 11838420
1. [Trimethoprim-sulfamethoxazole as antibacterial prophylaxis during induction therapy of children with acute lymphatic leukemia]. Agger KE, Schrøder H, Rosthøj S, Carlsen NT, Schmiegelow K. Ugeskr Laeger; 2002 Jan 21; 164(4):488-92. PubMed ID: 11838420 [Abstract] [Full Text] [Related]
3. Infections during induction therapy for children with acute lymphoblastic leukemia. the role of sulfamethoxazole-trimethoprim (SMX-TMP) prophylaxis. Rungoe C, Malchau EL, Larsen LN, Schroeder H. Pediatr Blood Cancer; 2010 Aug 21; 55(2):304-8. PubMed ID: 20583218 [Abstract] [Full Text] [Related]
4. Pneumocystis carinii pneumonia during maintenance treatment of childhood acute lymphoblastic leukemia. Poulsen A, Demeny AK, Bang Plum C, Gjerum Nielsen K, Schmiegelow K. Med Pediatr Oncol; 2001 Jul 21; 37(1):20-3. PubMed ID: 11466718 [Abstract] [Full Text] [Related]
5. A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation. Colby C, McAfee S, Sackstein R, Finkelstein D, Fishman J, Spitzer T. Bone Marrow Transplant; 1999 Oct 21; 24(8):897-902. PubMed ID: 10516703 [Abstract] [Full Text] [Related]
6. [Successful prevention of Pneumocystis carinii infection with 1,920 mg of trimethoprim-sulfamethoxazole daily in patients with malignant hematopoietic diseases]. Lemez P, Rysková P, Votava V, Suchmová M, Jirásek A, Rubík I. Vnitr Lek; 1995 Oct 21; 41(10):688-91. PubMed ID: 8578700 [Abstract] [Full Text] [Related]
7. Oral trimethoprim/sulfamethoxazole for prevention of bacterial infection during the induction phase of cancer chemotherapy in children. Kovatch AL, Wald ER, Albo VC, Prin W, Orlando SJ, Wollman MR, Phebus CK, Shapiro ED. Pediatrics; 1985 Nov 21; 76(5):754-60. PubMed ID: 3903647 [Abstract] [Full Text] [Related]
14. Successful prophylaxis against Pneumocystis carinii pneumonia in HIV-infected children using smaller than recommended dosages of trimethoprim-sulfamethoxazole. Fisher RG, Nageswaran S, Valentine ME, McKinney RE. AIDS Patient Care STDS; 2001 May 21; 15(5):263-9. PubMed ID: 11530767 [Abstract] [Full Text] [Related]
15. Prophylaxis of Pneumocystis carinii pneumonia with atovaquone in children with leukemia. Madden RM, Pui CH, Hughes WT, Flynn PM, Leung W. Cancer; 2007 Apr 15; 109(8):1654-8. PubMed ID: 17345613 [Abstract] [Full Text] [Related]
16. Effects of trimethoprim-sulfamethoxazole and insecticide-treated bednets on malaria among HIV-infected Ugandan children. Kamya MR, Gasasira AF, Achan J, Mebrahtu T, Ruel T, Kekitiinwa A, Charlebois ED, Rosenthal PJ, Havlir D, Dorsey G. AIDS; 2007 Oct 01; 21(15):2059-66. PubMed ID: 17885296 [Abstract] [Full Text] [Related]
17. Intermittent oral trimethoprim/sulfamethoxazole on two non-consecutive days per week is effective as Pneumocystis jiroveci pneumonia prophylaxis in pediatric patients receiving chemotherapy or hematopoietic stem cell transplantation. Ohata Y, Ohta H, Hashii Y, Tokimasa S, Ozono K, Hara J. Pediatr Blood Cancer; 2009 Jan 01; 52(1):142-4. PubMed ID: 18819150 [Abstract] [Full Text] [Related]
18. Methemoglobinemia in children with acute lymphoblastic leukemia (ALL) receiving dapsone for pneumocystis carinii pneumonia (PCP) prophylaxis: a correlation with cytochrome b5 reductase (Cb5R) enzyme levels. Williams S, MacDonald P, Hoyer JD, Barr RD, Athale UH. Pediatr Blood Cancer; 2005 Jan 01; 44(1):55-62. PubMed ID: 15390276 [Abstract] [Full Text] [Related]